Back to search

Article

Clinic and Genetic Factors Associated with Non Response to Erenumab

2025-11-18

Abstract excerpt

<h4>Background: </h4> Monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway, such as erenumab (ERE) are effective migraine preventive therapies for many patients. Identifying clinic and genetic factors associated with treatment failure is crucial for optimizing patients’ management. <h4>Methods:</h4> This multicenter, prospective observational study included patients with episodic or c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2840b6dd-5a29-517b-9c1a-b069cbaa2c1d
DOI
10.20944/preprints202511.1312.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinic and Genetic Factors Associated with Non Response to ErenumabDOI 10.20944/preprints202511.1312.v1
Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity
Association between response to triptans and response to erenumab: real-life dataSemantic proximity
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAESemantic proximity
Erenumab in highly therapy-refractory migraine patients First German Real-world evidenceSemantic proximity
Real-world Evidence Data on the Monoclonal Antibody Erenumab in Migraine Prevention: Perspectives of Treating Physicians in GermanySemantic proximity
Different Doses of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Network Meta-AnalysisSemantic proximity
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatmentSemantic proximity
Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world DataSemantic proximity
Predictors of galcanezumab response in a real-world study of Korean patients with migraineSemantic proximity
The impact of genetic factors on the response to migraine therapy.Semantic proximity
Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UKSemantic proximity
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity
Select a neighboring publication to make it the new centre.